Athanasios D Anastasilakis (A D Anastasilakis)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Topics

Postmenopausal Women

Magnetic Resonance

Bone Mineral Density

Top Venues

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Journal of clinical medicine

Hormones (Athens, Greece)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Palermo, Gaia Tabacco, Polyzois Makras, Guido Zavatta, Pierpaolo Trimboli, Elena Castellano, Maria P Yavropoulou, Anda Mihaela Naciu, Athanasios D Anastasilakis
Primary hyperparathyroidism: from guidelines to outpatient clinic. Reviews in endocrine & metabolic disorders (2024)
Ilias D Vachliotis, Athanasios D Anastasilakis, Rafailidis Vasileios, Stergios A Polyzos
Osteokines in Nonalcoholic Fatty Liver Disease. Current obesity reports (2024)
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, Matthaios Savvidis, Christos S Mantzoros
The comparative effect of teriparatide and denosumab on activins, follistatins and inhibins in women with postmenopausal osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2024)
Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou, Gaia Tabacco, Anda Mihaela Naciu, Elena Tsourdi
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when? European journal of endocrinology 191 (1) (2024)
Athanasios D Anastasilakis, Elena Tsourdi
Τhe story of sclerostin inhibition: the past, the present, and the future. Hormones (Athens, Greece) (2024)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Athanasios D Anastasilakis, Polyzois Makras, Julien Paccou, Ilias Bisbinas, Stergios A Polyzos, Socrates E Papapoulos
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab. Journal of clinical medicine 12 (18) (2023)
Athanasios D Anastasilakis, Stergios A Polyzos, Matthaios Savvidis, Dimitrios A Anastasilakis, Athanasios Sarridimitriou, Ajay Kumar, Bhanu Kalra, Polyzois Makras, Christos S Mantzoros
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study. Endocrine (2023)
Eleni Anastasilaki, Julien Paccou, Konstantinos Gkastaris, Athanasios D Anastasilakis
Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management. Hormones (Athens, Greece) (2023)
Polyzois Makras, Maria P Yavropoulou, Sofia N Chatziioannou, Athanasios D Anastasilakis, Danai Georgakopoulou, Marina Tsoli, Eleftherios Chatzelis, Grigorios Kaltsas
Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial. American journal of hematology (2023)
Athanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, Socrates E Papapoulos
The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis. Calcified tissue international (2023)
Polyzois Makras, Maria P Yavropoulou, Stergios A Polyzos, Socrates E Papapoulos, Danai Georgakopoulou, Athanasios Papatheodorou, Athanasios D Anastasilakis
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Athanasios D Anastasilakis, Stergios A Polyzos, Panagiotis A Vorkas, Athina Gkiomisi, Maria P Yavropoulou, Martina Rauner, Panagiotis Nikolakopoulos, Stergios Papachatzopoulos, Polyzois Makras, Spyridon Gerou, Lorenz C Hofbauer, Andrea Palermo, Elena Tsourdi
Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. Journal of clinical medicine 12 (16) (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens, Jean-Jacques Body
Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS". The Journal of clinical endocrinology and metabolism 107 (6) (2022)
Danae Georgakopoulou, Athanasios D Anastasilakis, Polyzois Makras
Adult Langerhans Cell Histiocytosis and the Skeleton. Journal of clinical medicine 11 (4) (2022)
Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens, Jean-Jacques Body
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. The Journal of clinical endocrinology and metabolism 107 (5) (2022)
Elena Tsourdi, Athanasios D Anastasilakis, Lorenz C Hofbauer, Martina Rauner, Franziska Lademann
Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature. Journal of clinical medicine 11 (22) (2022)
Athanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, Charikleia Ntenti, Stylianos Mandanas, Polyzois Makras
Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion. Endocrine 73 (1) (2021)
Elena Tsourdi, Athanasios D Anastasilakis
Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature. Biomedicines 9 (5) (2021)
Athanasios D Anastasilakis, Stergios A Polyzos, Dimitrios Kitridis, Polyzois Makras, Maria P Yavropoulou, Andrea Palermo, Spyridon Gerou, Charikleia Ntenti, Iris Ballaouri, Matthaios Savvidis
Ιrisin levels in postmenopausal women with an incident hip fracture. Endocrine 73 (3) (2021)
Athanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, Natasha M Appelman-Dijkstra, Charikleia Ntenti, Stylianos Mandanas, Athanasios Papatheodorou, Polyzois Makras
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation. Calcified tissue international 108 (5) (2021)
Athanasios D Anastasilakis, Elena Tsourdi, Gaia Tabacco, Anda Mihaela Naciu, Nicola Napoli, Fabio Vescini, Andrea Palermo
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News? Journal of clinical medicine 10 (5) (2021)
Kalliopi Lampropoulou-Adamidou, Georgios Trovas, Ioannis K Triantafyllopoulos, Maria P Yavropoulou, Athanasios D Anastasilakis, Panagiotis Anagnostis, Konstantinos A Toulis, Konstantinos Makris, Sousana Gazi, Alexia Balanika, Symeon Tournis
Teriparatide Treatment in Patients with Pregnancy- and Lactation-Associated Osteoporosis. Calcified tissue international 109 (5) (2021)
Polyzois Makras, Natasha M Appelman-Dijkstra, Socrates E Papapoulos, Sandra van Wissen, Elizabeth M Winter, Stergios A Polyzos, Maria P Yavropoulou, Athanasios D Anastasilakis
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Athanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, Gaia Tabacco, Anda Mihaela Naciu, Andrea Palermo
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review. Journal of clinical medicine 10 (1) (2021)
Athanasios D Anastasilakis, P Makras, A Doulgeraki, S A Polyzos, V Guarnieri, S E Papapoulos
Denosumab for the treatment of primary pediatric osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (11) (2021)
Polyzois Makras, Maria P Yavropoulou, Evanthia Kassi, Athanasios D Anastasilakis, Andromachi Vryonidou, Symeon Tournis
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society. Hormones (Athens, Greece) 19 (4) (2020)
Polyzois Makras, Athanasios D Anastasilakis
Questions and facts regarding denosumab discontinuation among postmenopausal women. Expert opinion on drug safety 20 (5) (2020)
Maria P Yavropoulou, Kalliopi Pazaitou-Panayiotou, John G Yovos, Christos Poulios, Athanasios D Anastasilakis, Dimitris Vlachodimitropoulos, Kyriakos Vambakidis, Olga Tsave, Sofia Chrisafi, Emily Daskalaki, Polyzois Makras
Circulating and Tissue Expression Profile of MicroRNAs in Primary Hyperparathyroidism Caused by Sporadic Parathyroid Adenomas. JBMR plus 5 (2) (2020)
Athanasios D Anastasilakis, Gerasimos Evangelatos, Polyzois Makras, Alexios Iliopoulos
Magnetic resonance imaging has an advantage over conventional spine X-rays in the evaluation of rebound-associated vertebral fractures following denosumab discontinuation. Endocrine 69 (3) (2020)
Athanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, Polyzois Makras
Combination and sequential treatment in women with postmenopausal osteoporosis. Expert opinion on pharmacotherapy 21 (4) (2020)
Athanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, Natasha M Appelman-Dijkstra, Polyzois Makras
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 34 (12) (2019)
Dimitrios A Anastasilakis, Polyzois Makras, Stergios A Polyzos, Athanasios D Anastasilakis, null null
Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview. Hormones (Athens, Greece) 18 (1) (2018)